Epstein-Barr Virus

Recent findings illuminate research in epstein-barr virus

Published in TB and Outbreaks Week, June 28th, 2005

Investigators in Taiwan and the United States have published new epstein-barr virus data.

Study 1: The effects of antiviral treatment on Epstein-Barr virus (EBV) gene expression have been characterized through real-time quantitative PCR analysis.

EBV "has the potential to undergo latent and lytic pathways during infection," virologists in Taiwan explained. "However, expression of many of the viral genes during the lytic-latent transition remains unclear."

In their study, Y.R. Pan and coauthors at National Tsing Hua University "investigated the effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and hydroxyurea (HU), two...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2005-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry